These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 30634986)
41. The lessons learned from the fentanyl overdose crises in British Columbia, Canada. Thomson E; Lampkin H; Maynard R; Karamouzian M; Jozaghi E Addiction; 2017 Nov; 112(11):2068-2070. PubMed ID: 28901045 [No Abstract] [Full Text] [Related]
42. Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies. Kryszajtys DT; Xavier J; Rudzinski K; Guta A; Chan Carusone S; Strike CJ Drug Alcohol Depend; 2022 Jan; 230():109179. PubMed ID: 34847503 [TBL] [Abstract][Full Text] [Related]
43. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada. Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156 [TBL] [Abstract][Full Text] [Related]
44. A Low-Barrier and Comprehensive Community-Based Harm-Reduction Site in Vancouver, Canada. Olding M; Ivsins A; Mayer S; Betsos A; Boyd J; Sutherland C; Culbertson C; Kerr T; McNeil R Am J Public Health; 2020 Jun; 110(6):833-835. PubMed ID: 32298171 [TBL] [Abstract][Full Text] [Related]
45. "Bed Bugs and Beyond": An ethnographic analysis of North America's first women-only supervised drug consumption site. Boyd J; Lavalley J; Czechaczek S; Mayer S; Kerr T; Maher L; McNeil R Int J Drug Policy; 2020 Apr; 78():102733. PubMed ID: 32247720 [TBL] [Abstract][Full Text] [Related]
46. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012. Kuo M; Shamsian A; Tzemis D; Buxton JA Harm Reduct J; 2014 Apr; 11():13. PubMed ID: 24766846 [TBL] [Abstract][Full Text] [Related]
48. Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada. Nassau T; Kolla G; Mason K; Hopkins S; Tookey P; McLean E; Werb D; Scheim A Harm Reduct J; 2022 Mar; 19(1):33. PubMed ID: 35351160 [TBL] [Abstract][Full Text] [Related]
49. Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids. Taylor J; Ober AJ; Kilmer B; Caulkins JP; Iguchi MY J Subst Abuse Treat; 2021 Dec; 131():108397. PubMed ID: 34098293 [TBL] [Abstract][Full Text] [Related]
50. "Taking away the chaos": a health needs assessment for people who inject drugs in public places in Glasgow, Scotland. Tweed EJ; Rodgers M; Priyadarshi S; Crighton E BMC Public Health; 2018 Jul; 18(1):829. PubMed ID: 29973179 [TBL] [Abstract][Full Text] [Related]
51. Barriers to health care in rural Mozambique: a rapid ethnographic assessment of planned mobile health clinics for ART. Schwitters A; Lederer P; Zilversmit L; Gudo PS; Ramiro I; Cumba L; Mahagaja E; Jobarteh K Glob Health Sci Pract; 2015 Mar; 3(1):109-16. PubMed ID: 25745124 [TBL] [Abstract][Full Text] [Related]
52. Rules and Eligibility Criteria for Supervised Consumption Services Feasibility Studies - A Scoping Review. Xavier J; Rudzinski K; Guta A; Carusone SC; Strike C Int J Drug Policy; 2021 Feb; 88():103040. PubMed ID: 33220597 [TBL] [Abstract][Full Text] [Related]
53. Acceptability of technological solutions for overdose monitoring: Perspectives of people who use drugs. Tsang VWL; Papamihali K; Crabtree A; Buxton JA Subst Abus; 2021; 42(3):284-293. PubMed ID: 31657675 [TBL] [Abstract][Full Text] [Related]
54. Drug checking at an electronic dance music festival during the public health overdose emergency in British Columbia. Mema SC; Sage C; Xu Y; Tupper KW; Ziemianowicz D; McCrae K; Leigh M; Munn MB; Taylor D; Corneil T Can J Public Health; 2018 Dec; 109(5-6):740-744. PubMed ID: 30251119 [TBL] [Abstract][Full Text] [Related]
55. Harm reduction in the hospital: An overdose prevention site (OPS) at a Canadian hospital. Nolan S; Kelian S; Kerr T; Young S; Malmgren I; Ghafari C; Harrison S; Wood E; Lysyshyn M; Holliday E Drug Alcohol Depend; 2022 Oct; 239():109608. PubMed ID: 36063622 [TBL] [Abstract][Full Text] [Related]
56. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia. Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249 [TBL] [Abstract][Full Text] [Related]
57. Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States. Mack KA; Jones CM; Ballesteros MF MMWR Surveill Summ; 2017 Oct; 66(19):1-12. PubMed ID: 29049278 [TBL] [Abstract][Full Text] [Related]
58. Expansion of antiretroviral treatment to rural health centre level by a mobile service in Mumbwa district, Zambia. Dube C; Nozaki I; Hayakawa T; Kakimoto K; Yamada N; Simpungwe JB Bull World Health Organ; 2010 Oct; 88(10):788-91. PubMed ID: 20931065 [TBL] [Abstract][Full Text] [Related]
59. "That's a double-edged sword": Exploring the integration of supervised consumption services within community health centres in Toronto, Canada. Bardwell G; Strike C; Mitra S; Scheim A; Barnaby L; Altenberg J; Kerr T Health Place; 2020 Jan; 61():102245. PubMed ID: 31740126 [TBL] [Abstract][Full Text] [Related]
60. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use. Baltes A; Devo B; Kaiser M; Birstler J; Brown RT WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]